Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial
乔垣结衣
16小时前
18
20
已关闭
DOI: 10.1016/S1470-2045(21)00460-5
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1470204521004605
其他信息:
出版社: Elsevier BV
作者: Hongyan Cheng; Liju Zong; Yujia Kong; Xiaoyu Wang; Yu Gu; Wei Cang; Jun Zhao; Xirun Wan; Junjun Yang; Yang Xiang